Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP<sub>82–98</sub>) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II

Design of Linear and Cyclic Mutant Analogues of Dirucotide Peptide (MBP<sub>82–98</sub>) against Multiple Sclerosis: Conformational and Binding Studies to MHC Class II

Background: Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system. MS is a T cell-mediated disease characterized by the proliferation, infiltration, and attack of the myelin sheath by immune cells. Previous studies have shown that cyclization provides molecules with strict...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: George Deraos, Eftichia Kritsi, Minos-Timotheos Matsoukas, Konstantina Christopoulou, Hubert Kalbacher, Panagiotis Zoumpoulakis, Vasso Apostolopoulos, John Matsoukas
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2018-12-01
Schriftenreihe:Brain Sciences
Schlagworte:
multiple sclerosis
MS
cyclic peptide
MBP
dirucotide
HLA-DR2
HLA-DR4
myelin basic protein
altered peptide ligand
Online Zugang:https://www.mdpi.com/2076-3425/8/12/213

Online

https://www.mdpi.com/2076-3425/8/12/213

Ähnliche Einträge